CSL (CSLLY) News Today $80.15 -0.40 (-0.50%) As of 07/9/2025 03:54 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsShort InterestBuy This Stock CSLLY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period CSL (OTCMKTS:CSLLY) Trading Down 0.5% - Time to Sell?July 10 at 2:20 AM | marketbeat.comCSL challenger staves off collapse after $37m lifelineJuly 3, 2025 | afr.comCSL (OTCMKTS:CSLLY) Shares Gap Down - Should You Sell?June 27, 2025 | marketbeat.comCBA.AX,CSL.AX,MQG.AX | Stock Prices | Quote Comparison - Yahoo FinanceJune 25, 2025 | finance.yahoo.comCDC report finds no link between thimerosal-containing vaccines and autismJune 24, 2025 | msn.comCSL (OTCMKTS:CSLLY) Trading Up 0.9% - Here's WhyJune 18, 2025 | marketbeat.comNew CDC vaccine experts to vote on mercury-based preservative in flu shotsJune 18, 2025 | msn.comU.S. Food and Drug Administration Approves CSL's ANDEMBRY® (garadacimab-gxii), the Only Prophylactic Hereditary Angioedema (HAE) Treatment Targeting Factor XIIa with Once-Monthly Dosing for All Patients From the StartJune 16, 2025 | prnewswire.comCSL Limited (OTCMKTS:CSLLY) Sees Large Increase in Short InterestJune 12, 2025 | marketbeat.comCSL Limited Appoints Cameron Price as Non-executive DirectorJune 9, 2025 | tipranks.comCSL Limited Announces Cessation of SecuritiesJune 3, 2025 | tipranks.comCSL (OTCMKTS:CSLLY) Trading Up 1.3% - Time to Buy?May 29, 2025 | marketbeat.comCSL (ASX:CSL) Secures NICE Approval For Sparsentan Use In NHS EnglandMay 23, 2025 | finance.yahoo.comEngland's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathyMay 23, 2025 | prnewswire.comCSL (OTCMKTS:CSLLY) Shares Up 0.5% - Here's WhyMay 8, 2025 | marketbeat.comCSL (ASX:CSL) Hosts Shareholder Information Meeting for Investor ClarityMay 6, 2025 | finance.yahoo.comCSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA NephropathyApril 29, 2025 | prnewswire.comLoop Capital Markets Sticks to Their Buy Rating for Carlisle Companies (CSL)April 25, 2025 | markets.businessinsider.comCSL Limited (OTCMKTS:CSLLY) Sees Significant Increase in Short InterestApril 16, 2025 | marketbeat.comCSL Limited Announces Cessation of SecuritiesApril 9, 2025 | tipranks.comCSL (OTCMKTS:CSLLY) Hits New 12-Month Low - What's Next?April 9, 2025 | marketbeat.comHow this Trump appointee could pressure the CSL share priceApril 8, 2025 | msn.comCSL, other big drug makers could be Trump’s next targetsApril 7, 2025 | afr.comCSL (OTCMKTS:CSLLY) Reaches New 52-Week Low - Should You Sell?April 1, 2025 | marketbeat.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Declines By 98.5%March 27, 2025 | marketbeat.comCSL Limited: Divergent Outlook For Its 2 Key BusinessesMarch 21, 2025 | seekingalpha.comCSL initiated with an Overweight at Morgan StanleyMarch 20, 2025 | markets.businessinsider.comCSL Recognized as One of Montreal's Top Employers for Seventh Consecutive YearMarch 18, 2025 | markets.businessinsider.comCSL Limited Announces Director’s Share AcquisitionMarch 16, 2025 | tipranks.comShort Interest in CSL Limited (OTCMKTS:CSLLY) Expands By 189.9%March 14, 2025 | marketbeat.comCSL Limited Announces Cessation of SecuritiesMarch 12, 2025 | tipranks.comCSL Limited Updates Dividend Distribution DetailsMarch 12, 2025 | tipranks.comCSL Limited Issues Unquoted Equity Securities Under Employee Incentive SchemeMarch 11, 2025 | tipranks.comCSL Limited Announces Quotation of New Securities on ASXMarch 10, 2025 | tipranks.comCSL (OTCMKTS:CSLLY) Shares Up 2.4% - Time to Buy?March 6, 2025 | marketbeat.comCSL Receives Approval in Japan for ANDEMBRY® (garadacimab) Subcutaneous (S.C.) Injection 200mg Pens, a Novel Human Anti-Activated Factor XII Monoclonal Antibody for the Prevention of Acute Attacks of Hereditary Angioedema (HAE)February 20, 2025 | prnewswire.comCSL Limited Director Updates Shareholding PositionFebruary 18, 2025 | tipranks.comCSL Limited Issues Unquoted Equity Securities for Employee IncentiveFebruary 18, 2025 | tipranks.comEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 VaccineFebruary 14, 2025 | prnewswire.comEuropean Commission Approves CSL and Arcturus Therapeutics' KOSTAIVE®, the First Self-amplifying mRNA COVID-19 VaccineFebruary 14, 2025 | businesswire.comRBC Capital Remains a Hold on CSL (CMXHF)February 14, 2025 | markets.businessinsider.comCSL Limited Earnings Call Highlights Growth and ChallengesFebruary 13, 2025 | tipranks.comCSL (CMXHF) Receives a Buy from JardenFebruary 13, 2025 | markets.businessinsider.comEuropean Commission Approves CSL's ANDEMBRY® (garadacimab) for the Prevention of Recurrent Attacks of Hereditary Angioedema (HAE)February 13, 2025 | prnewswire.comCSL Limited (OTCMKTS:CSLLY) Short Interest UpdateFebruary 12, 2025 | marketbeat.comCSL (CMXHF) Gets a Buy from JefferiesFebruary 12, 2025 | markets.businessinsider.comCSL reports $2 billion profit for H1 FY2025 but needs a stronger second halfFebruary 12, 2025 | au.investing.comIs CSL undervalued after earnings season wobble?February 11, 2025 | morningstar.com.auMCSL (CMXHF) Gets a Buy from Bell PotterFebruary 11, 2025 | markets.businessinsider.comCSL (OTCMKTS:CSLLY) Sets New 12-Month Low - Should You Sell?February 11, 2025 | marketbeat.com Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address CSLLY Media Mentions By Week CSLLY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CSLLY News Sentiment▼-0.270.56▲Average Medical News Sentiment CSLLY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CSLLY Articles This Week▼22▲CSLLY Articles Average Week Get CSL News Delivered to You Automatically Sign up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AZN News Today AMGN News Today GILD News Today VRTX News Today BMY News Today GSK News Today REGN News Today ALNY News Today ARGX News Today BNTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:CSLLY) was last updated on 7/10/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredHow a Kansas farm boy gained 1,285% in two daysA former farm kid placed a simple trade… and cashed out a 1,285% gain two days later. It wasn’t crypto or a...TradeSmith | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting—or plan to collect—Social Security, this could be a game-changer. A new initiative tie...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
